Left ventricular remodeling and its association with mineral and bone disorder in kidney transplant recipients

References

• Kochanek KD, Murphy SL, Xu J, et al. Deaths: final data for 2014. Natl Vital Stat Rep. 2016;65:1–9.
   PubMedGoogle Scholar
• Pickup LC, Law JP, Radhakrishnan A, et al. Changes in left ventricular structure and function associated with renal transplantation: a systematic review and meta-analysis. ESC Heart Fail. 2021;8(3):2045–2057. doi: 10.1002/ehf2.13283.
   PubMed Web of Science ®Google Scholar
• Cianciolo G, Capelli I, Angelini ML, et al. Importance of vascular calcification in kidney transplant recipients. Am J Nephrol. 2014;39(5):418–426. doi: 10.1159/000362492.
   PubMed Web of Science ®Google Scholar
• Gong IY, Al-Amro B, Prasad G, et al. Cardiovascular magnetic resonance left ventricular strain in end-stage renal disease patients after kidney transplantation. J Cardiovasc Magn Reson. 2018;20(1):83. doi: 10.1186/s12968-018-0504-5.
   PubMedGoogle Scholar
• Naylor KL, Li AH, Lam NN, et al. Fracture risk in kidney transplant recipients: a systematic review. Transplantation. 2013;95(12):1461–1470. doi: 10.1097/TP.0b013e31828eead8.
   PubMed Web of Science ®Google Scholar
• Nair SS, Lenihan CR, Montez-Rath ME, et al. Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States. Am J Transplant. 2014;14(4):943–951. doi: 10.1111/ajt.12652.
   PubMed Web of Science ®Google Scholar
• Benjamens S, Pol RA, Glaudemans A, et al. A high abdominal aortic calcification score by dual X-ray absorptiometry is associated with cardiovascular events after kidney transplantation. Nephrol Dial Transplant. 2018;33(12):2253–2259. doi: 10.1093/ndt/gfy158.
   PubMed Web of Science ®Google Scholar
• Lee SN, Cho JY, Eun YM, et al. Associations between osteoporosis and coronary artery disease in postmenopausal women. Climacteric. 2016;19(5):458–462. doi: 10.1080/13697137.2016.1200550.
   PubMed Web of Science ®Google Scholar
• Huang C, Li S. Correlation research between osteoporosis and left ventricular hypertrophy in older men. Arch Med Sci. 2016;12(6):1220–1224. doi: 10.5114/aoms.2016.62910.
   PubMed Web of Science ®Google Scholar
• Lim YH, Shin J, Lee JU, et al. Bone mineral density is an independent determinant of left ventricular mass index in the general female population. Korean Circ J. 2010;40(11):573–580. doi: 10.4070/kcj.2010.40.11.573.
   PubMedGoogle Scholar
• Sun L, Wang Z, Zheng M, et al. Mineral and bone disorder after kidney transplantation: a single-center cohort study. Ren Fail. 2023;45:2210231.
   PubMed Web of Science ®Google Scholar
• Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO study group. Osteoporos Int. 1994;4(6):368–381. doi: 10.1007/BF01622200.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55(4):613–618. doi: 10.1161/01.cir.55.4.613.
   PubMed Web of Science ®Google Scholar
• Jørgensen HS, Behets G, Bammens B, et al. Natural history of bone disease following kidney transplantation. J Am Soc Nephrol. 2022;33(3):638–652. doi: 10.1681/ASN.2021081081.
   PubMed Web of Science ®Google Scholar
• Ferreira AC, Mendes M, Silva C, et al. Improvement of mineral and bone disorders after renal transplantation. Transplantation. 2022;106(5):e251–e261. doi: 10.1097/TP.0000000000004099.
   PubMed Web of Science ®Google Scholar
• Arnol M, Knap B, Oblak M, et al. Subclinical left ventricular echocardiographic abnormalities 1 year after kidney transplantation are associated with graft function and future cardiovascular events. Transplant Proc. 2010;42(10):4064–4068. doi: 10.1016/j.transproceed.2010.09.044.
   PubMed Web of Science ®Google Scholar
• Salari A, Monfared A, Fahim SH, et al. The survey of diastolic function changes in end-stage renal disease patients before and 3 and 6 months after kidney transplantation. Transplant Proc. 2012;44(10):3007–3012. doi: 10.1016/j.transproceed.2012.03.060.
   PubMed Web of Science ®Google Scholar
• Džemidžić J, Rašić S, Saračević A, et al. Predictors of left ventricular remodelling in kidney transplant recipents in the first posttransplant year. Bosn J of Basic Med Sci. 2010;10(1):51. doi: 10.17305/bjbms.2010.2649.
   Google Scholar
• Montanaro D, Gropuzzo M, Tulissi P, et al. Effects of successful renal transplantation on left ventricular mass. Transplant Proc. 2005;37(6):2485–2487. doi: 10.1016/j.transproceed.2005.06.022.
   PubMed Web of Science ®Google Scholar
• Vaidya OU, House JA, Coggins TR, et al. Effect of renal transplantation for chronic renal disease on left ventricular mass. Am J Cardiol. 2012;110(2):254–257. doi: 10.1016/j.amjcard.2012.02.067.
   PubMed Web of Science ®Google Scholar
• Sreedharan S, Mathew A, Paul Z, et al. Changes in left ventricular mass and cardiovascular risk factors after kidney transplantation. Saudi J Kidney Dis Transpl. 2020;31(5):1006–1013. doi: 10.4103/1319-2442.301165.
   PubMed Web of Science ®Google Scholar
• Prasad G, Yan AT, Nash MM, et al. Determinants of left ventricular characteristics assessed by cardiac magnetic resonance imaging and cardiovascular biomarkers related to kidney transplantation. Can J Kidney Health Dis. 2018;5:205435811880997. doi: 10.1177/2054358118809974.
   Google Scholar
• Omran MT, Khakpour S, Oliaie F. Left ventricular function before and after kidney transplantation. Saudi Med J. 2009;30(6):821–823.
   PubMed Web of Science ®Google Scholar
• Jasminka D, Rasic S, Rebic D, et al. Role of hypertension and anaemia in left ventricular remodelling in patient with renal allograft in the first post-transplant year. Mater Sociomed. 2015;27(2):104–107. doi: 10.5455/msm.2015.27.104-107.
   PubMedGoogle Scholar
• Liefeldt L, Budde K. Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk. Transpl Int. 2010;23(12):1191–1204. doi: 10.1111/j.1432-2277.2010.01159.x.
   PubMed Web of Science ®Google Scholar
• Saleh FN, Schirmer H, Sundsfjord J, et al. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J. 2003;24(22):2054–2060. doi: 10.1016/j.ehj.2003.09.010.
   PubMed Web of Science ®Google Scholar
• Parfrey PS, Harnett JD, Foley RN, et al. Impact of renal transplantation on uremic cardiomyopathy. Transplantation. 1995;60(11):908–913. doi: 10.1097/00007890-199511000-00005.
   PubMedGoogle Scholar
• Massimetti C, Imperato G, Feriozzi S. Correction of secondary hyperparathyroidism with paricalcitol in renal transplant improves left ventricular hypertrophy. G Ital Nefrol. 2019;36(1):2019-vol1.
   Google Scholar
• Park CW, Oh YS, Shin YS, et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis. 1999;33(1):73–81. doi: 10.1016/s0272-6386(99)70260-x.
   PubMed Web of Science ®Google Scholar
• Wolf M, Molnar MZ, Amaral AP, et al. Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol. 2011;22(5):956–966. doi: 10.1681/ASN.2010080894.
   PubMed Web of Science ®Google Scholar
• Faul C, Amaral AP, Oskouei B, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011;121(11):4393–4408. doi: 10.1172/JCI46122.
   PubMed Web of Science ®Google Scholar
• Masugata H, Senda S, Murao K, et al. Reduced bone mineral density in hypertensive patients is associated with left ventricular diastolic dysfunction, not left ventricular hypertrophy. Clin Exp Hypertens. 2012;34(3):176–181. doi: 10.3109/10641963.2011.577490.
   PubMed Web of Science ®Google Scholar
• Verheyen N, Fahrleitner-Pammer A, Belyavskiy E, et al. Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: the EPATH trial. PLOS One. 2017;12(4):e0173799. doi: 10.1371/journal.pone.0173799.
   PubMed Web of Science ®Google Scholar
• Hmamouchi I, Allali F, Khazzani H, et al. Low bone mineral density is related to atherosclerosis in postmenopausal Moroccan women. BMC Public Health. 2009;9(1):388. doi: 10.1186/1471-2458-9-388.
   PubMedGoogle Scholar
• Hernández D, González A, Rufino M, et al. Time-dependent changes in cardiac growth after kidney transplantation: the impact of pre-dialysis ventricular mass. Nephrol Dial Transplant. 2007;22(9):2678–2685. doi: 10.1093/ndt/gfm247.
   PubMed Web of Science ®Google Scholar
• Gupta J, Dominic EA, Fink JC, et al. Association between inflammation and cardiac geometry in chronic kidney disease: findings from the CRIC study. PLOS One. 2015;10(4):e0124772. doi: 10.1371/journal.pone.0124772.
   PubMed Web of Science ®Google Scholar
• Sezer S, Erkmen UM, Tutal E, et al. New-onset diabetes and glucose regulation are significant determinants of left ventricular hypertrophy in renal transplant recipients. J Diabetes Res. 2015;2015:293896–293899. doi: 10.1155/2015/293896.
   PubMed Web of Science ®Google Scholar